Crushing GI on Your FNP Boards: Essential Concepts & Clinical Pearls for Success
Gastroenterology · 6 min read · June 23, 2026
Crushing GI on Your FNP Boards: Essential Concepts & Clinical Pearls for Success
Hey future FNPs! Gastroenterology (GI) is a huge topic on your board exams, covering everything from common heartburn to complex inflammatory bowel diseases. It can feel overwhelming, but with a focused approach, you can master the high-yield concepts and confidently answer those challenging GI questions. Let's break down some key areas you absolutely need to know.
GERD, PUD, and H. pylori: The Upper GI Trio
When it comes to upper GI, Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) are board favorites. You'll need to differentiate them and understand their management.
GERD is chronic symptoms or mucosal damage caused by stomach acid refluxing into the esophagus. Patients often report heartburn (pyrosis), regurgitation, and sometimes atypical symptoms like chronic cough or hoarseness. Diagnosis is primarily clinical, based on symptoms. An upper endoscopy is usually reserved for patients with alarm symptoms (dysphagia, odynophagia, weight loss, GI bleeding, anemia) or those refractory to treatment.
Treatment starts with lifestyle modifications (avoiding trigger foods, smaller meals, elevating the head of the bed, weight loss). Proton Pump Inhibitors (PPIs) like omeprazole or pantoprazole are the most effective medications, often prescribed once daily before the first meal. H2 receptor antagonists (H2RAs) are an alternative for milder symptoms or as add-on therapy.
PUD involves open sores that develop on the inside lining of the stomach (gastric ulcers) or the upper part of the small intestine (duodenal ulcers). The two main causes are Helicobacter pylori (H. pylori) infection and NSAID use. Patients typically present with epigastric pain, which can be burning, gnawing, or aching. Duodenal ulcer pain often improves with food and worsens 2-3 hours after eating, while gastric ulcer pain may worsen with food.
Diagnosis involves upper endoscopy with biopsy to rule out malignancy, especially for gastric ulcers. For H. pylori, you'll need to know about urea breath tests, stool antigen tests, and biopsy during endoscopy. Serology is less useful for confirming eradication as antibodies can persist.
Treatment for PUD involves acid suppression (PPIs) and, if H. pylori is present, eradication therapy (usually a triple or quadruple therapy regimen for 10-14 days). Always re-test for H. pylori eradication 4-6 weeks after treatment completion, especially if symptoms persist.
Clinical Pearl: Remember that alarm symptoms (dysphagia, odynophagia, weight loss, GI bleeding, anemia) in any GI patient warrant prompt investigation with an upper endoscopy, regardless of initial symptom presentation. Don't just treat empirically when these red flags are present.
Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD): Differentiating Chronic Bowel Conditions
These two conditions often confuse students, but understanding their key differences is crucial for boards.
Irritable Bowel Syndrome (IBS) is a functional GI disorder characterized by chronic abdominal pain associated with altered bowel habits (constipation, diarrhea, or mixed). It's diagnosed using the Rome IV criteria, which require recurrent abdominal pain, on average, at least one day per week for the past three months, associated with two or more of the following: related to defecation, associated with a change in frequency of stool, or associated with a change in form (appearance) of stool. The key here is that there's no structural or biochemical abnormality found on diagnostic tests.
Management focuses on symptom control: dietary changes (e.g., FODMAP diet), fiber supplements, antispasmodics, laxatives, anti-diarrheals, and sometimes antidepressants. Patient education and reassurance are vital.
Inflammatory Bowel Disease (IBD), which includes Crohn's Disease and Ulcerative Colitis (UC), is a chronic inflammatory condition of the GI tract. Unlike IBS, IBD involves actual inflammation and structural changes.
- Crohn's Disease: Can affect any part of the GI tract from mouth to anus, but most commonly the terminal ileum and colon. It's characterized by transmural inflammation (affecting all layers of the bowel wall) and skip lesions (diseased areas separated by normal tissue). Patients may present with abdominal pain, diarrhea (often non-bloody), weight loss, and sometimes perianal disease (fistulas, abscesses).
- Ulcerative Colitis: Affects only the colon and rectum, starting distally and extending proximally in a continuous fashion. Inflammation is typically limited to the mucosa and submucosa. Symptoms include bloody diarrhea, tenesmus, and abdominal pain.
Diagnosis of IBD involves endoscopy (colonoscopy with biopsy), imaging (CT/MRI enterography), and lab markers (elevated ESR/CRP, fecal calprotectin). Treatment is complex and involves anti-inflammatory medications (aminosalicylates), corticosteroids, immunomodulators, and biologics.
Board Tip: Remember that IBS is a diagnosis of exclusion after ruling out other organic causes, especially IBD. If a patient presents with chronic abdominal pain and altered bowel habits, but also has alarm symptoms (weight loss, nocturnal diarrhea, GI bleeding, anemia, family history of IBD/colon cancer), you must investigate further for IBD or other organic pathology.
Liver Function Tests (LFTs) and Hepatitis
Understanding LFTs and the different types of hepatitis is essential. LFTs are a panel of blood tests that give us clues about liver health.
- Hepatocellular injury: Elevated ALT (alanine aminotransferase) and AST (aspartate aminotransferase). ALT is more specific to the liver. High levels suggest liver cell damage.
- Cholestasis: Elevated Alkaline Phosphatase (ALP) and GGT (gamma-glutamyl transferase). High levels suggest bile duct obstruction or damage. GGT helps confirm if an elevated ALP is liver-related.
- Synthetic function: Albumin (decreased in chronic liver disease) and PT/INR (prolonged in acute or chronic severe liver disease due to decreased clotting factor production).
Hepatitis refers to inflammation of the liver, most commonly caused by viruses (A, B, C, D, E). You need to know the transmission, serology, and basic management for each.
- Hepatitis A (HAV): Fecal-oral transmission. Acute infection only, no chronic state. Diagnosed by IgM anti-HAV. Preventable by vaccine.
- Hepatitis B (HBV): Blood-borne, sexual, perinatal transmission. Can be acute or chronic. Complex serology is a board favorite! Key markers:
- HBsAg: Indicates active infection (acute or chronic).
- Anti-HBs: Indicates immunity (from vaccination or past resolved infection).
- Anti-HBc IgM: Indicates acute infection.
- Anti-HBc total: Indicates past or current infection.
- HBeAg: Indicates high infectivity.
Preventable by vaccine.
- Hepatitis C (HCV): Blood-borne transmission. Often asymptomatic, leads to chronic infection in 75-85% of cases, which can progress to cirrhosis and hepatocellular carcinoma. Diagnosed by anti-HCV antibody screening, followed by HCV RNA to confirm active infection. No vaccine, but highly curable with direct-acting antivirals (DAAs).
Board Tip: When interpreting Hepatitis B serology, focus on HBsAg (active infection) and Anti-HBs (immunity). If both are negative, the patient is susceptible and needs vaccination. If HBsAg is positive, the patient has an active infection. If Anti-HBs is positive and HBsAg is negative, the patient is immune.
Conquering GI on Your Boards
Gastroenterology might seem vast, but by focusing on these high-yield topics – understanding the pathophysiology, key diagnostic criteria, and first-line treatments – you'll build a strong foundation. Remember to look for those alarm symptoms and always think about the most common causes for each condition. You've got this!
Ready to put your GI knowledge to the test? Visit store.thefnpreview.com for comprehensive board prep resources, including thousands of practice questions designed to help you succeed.